U.S. FDA advisers back Moderna COVID-19 vaccine for small children
(Reuters) – U.S. Food and Drug Administration advisers on Wednesday recommended the authorization of Moderna Inc’s COVID-19 vaccine for children aged 6 months through 5 years, an important step toward immunizing millions children who have been ineligible for the shots during the pandemic. The same panel of outside experts is expected to vote within an …
U.S. FDA advisers back Moderna COVID-19 vaccine for small children Read More »








